Balter Invenomic Financials

BIVIX Fund  USD 17.94  0.12  0.66%   
You can use fundamental analysis to find out if Balter Invenomic is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to collect and analyze data for twelve available fundamental indicators for Balter Invenomic Fund, which can be compared to its peers. The fund experiences a moderate downward daily trend and can be a good diversifier. Check odds of Balter Invenomic to be traded at $17.58 in 90 days.
  
Please note that you must use caution to infer results of funds future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.

Balter Invenomic Fund Summary

Balter Invenomic competes with Morningstar Municipal, California Municipal, T Rowe, Limited Term, and Intermediate-term. The fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Invenomic Fund is traded on NASDAQ Exchange in the United States.
Specialization
Long-Short Equity, Large
InstrumentUSA Mutual Fund View All
ExchangeNMFQS Exchange
Business AddressNorthern Lights
Mutual Fund FamilyInvenomic
Mutual Fund CategoryLong-Short Equity
BenchmarkDow Jones Industrial
Phone844 322 8112
CurrencyUSD - US Dollar

Balter Invenomic Key Financial Ratios

Balter Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Balter Invenomic's current stock value. Our valuation model uses many indicators to compare Balter Invenomic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Balter Invenomic competition to find correlations between indicators driving Balter Invenomic's intrinsic value. More Info.
Balter Invenomic Fund is the top fund in annual yield among similar funds. It also is the top fund in year to date return among similar funds creating about  92.14  of Year To Date Return per Annual Yield. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Balter Invenomic's earnings, one of the primary drivers of an investment's value.

Balter Invenomic Systematic Risk

Balter Invenomic's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Balter Invenomic volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Balter Invenomic correlated with the market. If Beta is less than 0 Balter Invenomic generally moves in the opposite direction as compared to the market. If Balter Invenomic Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Balter Invenomic is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Balter Invenomic is generally in the same direction as the market. If Beta > 1 Balter Invenomic moves generally in the same direction as, but more than the movement of the benchmark.
Balter Invenomic Fund is the top fund in net asset among similar funds. Total Asset Under Management (AUM) of Long-Short Equity category is currently estimated at about 18.2 Billion. Balter Invenomic holds roughly 1.4 Billion in net asset claiming about 8% of funds under Long-Short Equity category.

Balter Invenomic March 24, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Balter Invenomic help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Balter Invenomic Fund. We use our internally-developed statistical techniques to arrive at the intrinsic value of Balter Invenomic Fund based on widely used predictive technical indicators. In general, we focus on analyzing Balter Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Balter Invenomic's daily price indicators and compare them against related drivers.

Other Information on Investing in Balter Mutual Fund

Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas